Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Dolnoslaskie Centrum Onkologii. (Site 1712)

Wroclaw, Lower Silesian Voivodeship 53-413, PolandEU-13 widening countryNot linked to an institution yet

1closed trial

Closed trials

Completed
Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)
NCT04662710· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Dolnoslaskie Centrum Onkologii. (Site 1712): trial site – Frontlight Research